|  Help  |  About  |  Contact Us

Publication : A Novel Loss-of-Function <i>SEMA3E</i> Mutation in a Patient with Severe Intellectual Disability and Cognitive Regression.

First Author  Paganoni AJJ Year  2022
Journal  Int J Mol Sci Volume  23
Issue  10 PubMed ID  35628442
Mgi Jnum  J:325108 Mgi Id  MGI:7283233
Doi  10.3390/ijms23105632 Citation  Paganoni AJJ, et al. (2022) A Novel Loss-of-Function SEMA3E Mutation in a Patient with Severe Intellectual Disability and Cognitive Regression. Int J Mol Sci 23(10)
abstractText  Intellectual disability (ID) is a neurological disorder arising from early neurodevelopmental defects. The underlying genetic and molecular mechanisms are complex, but are thought to involve, among others, alterations in genes implicated in axon guidance and/or neural circuit formation as demonstrated by studies on mouse models. Here, by combining exome sequencing with in silico analyses, we identified a patient affected by severe ID and cognitive regression, carrying a novel loss-of-function variant in the semaphorin 3E (SEMA3E) gene, which encodes for a key secreted cue that controls mouse brain development. By performing ad hoc in vitro and ex vivo experiments, we found that the identified variant impairs protein secretion and hampers the binding to both embryonic mouse neuronal cells and tissues. Further, we revealed SEMA3E expression during human brain development. Overall, our findings demonstrate the pathogenic impact of the identified SEMA3E variant and provide evidence that clinical neurological features of the patient might be due to a defective SEMA3E signaling in the brain.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

2 Bio Entities

0 Expression